Home
Search
Search Only:

Search Keyword safety

Total: 49 results found.

Page 1 of 3
... substantial efficacy in treating relapsing-remitting MS and that safety of the proposed 0.5 mg dose justified approval.... [Read More] Read more: MSRC Latest MS News  ...
... of patients with spinal cord injuries that had been placed on hold for nearly a year because of safety concerns. If the treatment from Geron works, it "would be revolutionary," said Dr. Richard ...
... area, which will be detrimental to highway safety" and will have a "negative and unacceptable impact on the amenity of surrounding residents". People behind the new MS centre have said they will appeal ...
... to be approved for RRMS patients and this news comes as a blow to Merck Serono, days after it announced the resubmission of oral cladribine. However, despite concerns over safety, Datamonitor believe ...
... into practice, overwhelming our ability to evaluate their safety and effectiveness. Regulating the complex process of developing and testing procedures won?t work. Rather, we need to build a new and ongoing ...
Genmab A/S announced today positive interim results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS). A total of 38 patients ...
... safety and quality. The International Society for Stem Cell Research has issued patient guidelines. Source: guardian.co.uk  © Guardian News and Media Limited 2010 (11/01/10)  ...
... associated with multiple sclerosis (MS). This study evaluated the safety of CCSVI endovascular treatment and its influence on the clinical outcome of the associated MS. Methods Sixty-five consecutive ...
... and safety data from pivotal Betaferon clinical trials, along with findings from a single-arm study designed to demonstrate the efficacy and safety of Betaferon among Chinese patients with relapsing-remitting ...
... with cancer during a final-stage trial of cladribine. An independent monitoring board was aware of the cases but didn’t consider them a safety concern, Merck said at the time. Cancer Each of the four ...
... TRIAL DESIGN The STAR (Safety, Tolerability and Efficacy Results of AVP-923 in PBA) trial is a confirmatory Phase III trial of Zenvia in patients with pseudobulbar affect (PBA). The randomized, multi-center, ...
... is available in compounding pharmacies. A compounding pharmacy makes drugs from ingredients that physicians prescribe, but are not regulated by the FDA from a safety standpoint. There have been cases of ...
Different methods of weighing the risks and benefits of medical treatments lead to varying conclusions about their safety Ever since the powerful multiple sclerosis drug Tysabri returned to the market ...
... which is likely due to their perceived advantages in efficacy, safety, and/or convenience compared with current drugs. Multiple Sclerosis: How Will Clinician Attitudes and Reimbursement Issues Determine ...
... Thrombocytopenic Purpura (ITP), an autoimmune disease characterised by a low count of thrombocytes. A Phase I trial in about 42 male volunteers to assess the safety and tolerability of intravenously administered ...
16. Safety call over stem cell trips
(News/MS Research)
... the short-term and long-term prognosis and the things we don't know about the risks." Recommendations Bionet is recommending that the safety and efficiency of stem cell treatments is investigated ...
... SELECT phase 2b monotherapy study of DAC HYP in MS as they plan for the phase 3 study. The independent Safety Monitoring Committee (SMC) for the SELECT study conducted a planned interim futility analysis ...
... a biotechnology company based in Menlo Park, will conduct first-phase safety trials for a procedure involving the injection of embryonic stem cells into human patients with spinal cord injuries. The hope ...
... brought back in 2006 with stricter safety warnings. Biogen has recently adopted a more aggressively upbeat tone in marketing the drug, insisting physicians are becoming more comfortable with risk of PML. ...
... the safety and effectiveness of the stem cell therapy and MS drugs. Source: www.scientificamerican.com 07/23/09  ...
«StartPrev123NextEnd»